表紙
市場調查報告書

體外膜氧合器(Ecmo)系統全球市場預測(2019-2028)

Global Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028

出版商 Inkwood Research 商品編碼 953132
出版日期 內容資訊 英文 177 Pages
商品交期: 2-3個工作天內
價格
體外膜氧合器(Ecmo)系統全球市場預測(2019-2028) Global Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028
出版日期: 2020年08月10日內容資訊: 英文 177 Pages
簡介

在預測期內(2019-2028年),全球體外膜氧合器(Ecmo)系統市場預計將以4.74%的複合年增長率增長。慢性疾病負擔的增加,ECMO技術的使用增加以及技術進步正在推動該市場的增長。 Genitage AB的CardioHelp系統是EMCO系統之一。它的特點是緊湊,重量輕和便攜性,主要用於呼吸和心肌衰竭,同時支持心臟和肺部。這些技術進步有望為市場增長做出貢獻。但是,缺乏與ECMO系統相關的專業知識和成本正在阻礙市場增長。

本報告調查了全球體外膜氧合器(Ecmo)系統市場,其中包括市場增長和約束,COVID-19的影響,按方式/用途/地區和競爭進行的市場分析。我們提供有關主要公司的狀況和概況的信息。

目錄

第1章調查範圍和調查方法

  • 調查目的
  • 調查範圍
  • 調查方法
  • 先決條件和限制

第2章執行摘要

  • 市場規模和估計
  • 市場概況

第3章市場動態

  • 市場定義
  • 主要增長因素
    • 越來越多地使用ECMO技術
    • 技術進步
    • 嚴重的慢性疾病
  • 主要製約因素
    • 缺乏專業
    • ECMO系統的高成本
    • 與ECMO系統有關的副作用
    • 常規技術的存在

第4章主要分析

  • 波特的五力分析
  • COVID-19對ECMO系統市場的影響
  • 市場機會矩陣
  • 供應商狀況
  • 主要投資見解

第5章市場分析:按方式

  • VENO-VENOUS
  • VENO-ARTERIAL
  • 其他

第6章市場分析:按用法

  • 呼吸系統
  • 心臟
  • 體外心肺復甦(ECPR)

第7章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 俄羅斯
    • 比利時
    • 波蘭
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞/新西蘭
    • 韓國
    • 泰國
    • 印度尼西亞
    • 越南
    • 其他
  • 其他地區
    • 拉丁美洲
    • 中東/非洲

第8章公司簡介

  • ABBOTT LABORATORIES
  • ALUNG TECHNOLOGIES INC
  • ELSIUS BIOMEDICAL INC
  • EUROSETS
  • GETINGE AB
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • MICROPORT SCIENTIFIC CORPORATION
  • NIPRO CORPORATION
  • ORIGEN BIOMEDICAL INC
  • SPECTRUM MEDICAL
  • TERUMO MEDICAL CORPORATION
  • XENIOS AG (FRESENIUS SE & CO KGAA)
目錄
Product Code: 33030

KEY FINDINGS

The global extra corporeal membrane oxygenation (ECMO) system market is projected to record a CAGR of 4.74% during the forecast period, 2019-2028. The rising burden of chronic disorders, growing usage of ECMO technology, and technological advancements, are set to propel the growth of the market.

MARKET INSIGHTS

The ECMO is used for critically ill patients and neonates. It is popular for providing life support for longer durations. The advent of new technologies is increasing the applications of ECMO technology. This includes enabling it for inter- and intra-hospital transport. Short-term and long-term applications have undergone considerable technological advancements. Modern ECMO technology has improved biocompatibility and portability, and offers a simple and safe way of provision.

The CardioHelp System by Genitage AB is an EMCO system. Its features are compact, light-weight, and portability. It supports both the heart and lungs. It is primarily used in the cases of respiratory and myocardial failure, and has a lifespan of almost 30 days. Such advancements in technologies are projected to contribute to the growth of the market. However, the lack of specialized expertise and the expenses involved in the ECMO system, pose a hindrance to market growth.

REGIONAL INSIGHTS

The geographical segregation of the global extra corporeal membrane oxygenation (ECMO) system market includes the analysis of North America, Asia Pacific, Europe, and the rest of the world. North America is projected to dominate the global market by 2028. The rising number of cardiovascular disease cases is attributed to the enhanced prospects of the market.

COMPETITIVE INSIGHTS

The companies are prioritizing innovation to sustain the competitive environment. Some of the leading companies in the market include, Elsius Biomedical Inc, Livanova Plc, Getinge AB, Alung Technologies Inc, Eurosets, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASED USAGE OF ECMO TECHNOLOGY
    • 3.2.2. TECHNOLOGICAL ADVANCEMENT
    • 3.2.3. GROWING BURDEN OF CHRONIC DISORDERS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF SPECIALIZED EXPERTISE
    • 3.3.2. HIGH COST OF ECMO SYSTEM
    • 3.3.3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
    • 3.3.4. PRESENCE OF CONVENTIONAL TECHNIQUES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY MODALITY

  • 5.1. VENO-VENOUS
  • 5.2. VENO-ARTERIAL
  • 5.3. OTHER MODALITIES

6. MARKET BY APPLICATION

  • 6.1. RESPIRATORY
  • 6.2. CARDIAC
  • 6.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. RUSSIA
    • 7.2.6. BELGIUM
    • 7.2.7. POLAND
    • 7.2.8. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. JAPAN
    • 7.3.3. INDIA
    • 7.3.4. AUSTRALIA & NEW ZEALAND
    • 7.3.5. SOUTH KOREA
    • 7.3.6. THAILAND
    • 7.3.7. INDONESIA
    • 7.3.8. VIETNAM
    • 7.3.9. REST OF ASIA PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. ALUNG TECHNOLOGIES INC
  • 8.3. ELSIUS BIOMEDICAL INC
  • 8.4. EUROSETS
  • 8.5. GETINGE AB
  • 8.6. LIVANOVA PLC
  • 8.7. MEDTRONIC PLC
  • 8.8. MICROPORT SCIENTIFIC CORPORATION
  • 8.9. NIPRO CORPORATION
  • 8.10. ORIGEN BIOMEDICAL INC
  • 8.11. SPECTRUM MEDICAL
  • 8.12. TERUMO MEDICAL CORPORATION
  • 8.13. XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM
  • TABLE 2: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL VENO-VENOUS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL VENO-VENOUS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL VENO-ARTERIAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL VENO-ARTERIAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL OTHER MODALITIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL OTHER MODALITIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL RESPIRATORY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL RESPIRATORY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL CARDIAC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL CARDIAC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION MARKET, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIST OF CHRONIC DISEASES
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019
  • FIGURE 7: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019
  • FIGURE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: THE UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 16: CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 18: THE UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 20: FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 21: ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 22: RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: BELGIUM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: POLAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 26: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 27: CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: THAILAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: INDONESIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: VIETNAM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: REST OF ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 37: LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: MIDDLE EAST & AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)